Christine Marie Dieckhaus - Publications

Affiliations: 
2001 University of Virginia, Charlottesville, VA 

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Deveau AM, Labroli MA, Dieckhaus CM, Barthen MT, Smith KS, Macdonald TL. ChemInform Abstract: Synthesis of Amino-Acid Functionalized β-Carbolines as Topoisomerase II Inhibitors. Cheminform. 32: no-no. DOI: 10.1002/chin.200137147  0.713
2008 Jain HD, Zhang C, Zhou S, Zhou H, Ma J, Liu X, Liao X, Deveau AM, Dieckhaus CM, Johnson MA, Smith KS, Macdonald TL, Kakeya H, Osada H, Cook JM. Synthesis and structure-activity relationship studies on tryprostatin A, an inhibitor of breast cancer resistance protein. Bioorganic & Medicinal Chemistry. 16: 4626-51. PMID 18321710 DOI: 10.1016/J.Bmc.2008.02.050  0.71
2002 Kapetanovic IM, Torchin CD, Strong JM, Yonekawa WD, Lu C, Li AP, Dieckhaus CM, Santos WL, Macdonald TL, Sofia RD, Kupferberg HJ. Reactivity of atropaldehyde, a felbamate metabolite in human liver tissue in vitro Chemico-Biological Interactions. 142: 119-134. PMID 12399159 DOI: 10.1016/S0009-2797(02)00058-3  0.723
2002 Dieckhaus CM, Thompson CD, Roller SG, Macdonald TL. Mechanisms of idiosyncratic drug reactions: The case of felbamate Chemico-Biological Interactions. 142: 99-117. PMID 12399158 DOI: 10.1016/S0009-2797(02)00057-1  0.733
2002 Roller SG, Dieckhaus CM, Santos WL, Sofia RD, Macdonald TL. Interaction between human serum albumin and the felbamate metabolites 4-Hydroxy-5-phenyl-[1,3]oxazinan-2-one and 2-phenylpropenal. Chemical Research in Toxicology. 15: 815-24. PMID 12067249 DOI: 10.1021/Tx025509H  0.746
2002 Zhao S, Smith KS, Deveau AM, Dieckhaus CM, Johnson MA, Macdonald TL, Cook JM. Biological activity of the tryprostatins and their diastereomers on human carcinoma cell lines. Journal of Medicinal Chemistry. 45: 1559-62. PMID 11931609 DOI: 10.1021/Jm0155953  0.706
2002 Roller SG, Dieckhaus CM, Santos WL, Sofia RD, Macdonald TL. Interaction between human serum albumin and the felbamate metabolites 4-hydroxy-5-phenyl-[1,3]oxazinan-2-one and 2-phenylpropenal Chemical Research in Toxicology. 15: 815-824. DOI: 10.1021/tx025509h  0.721
2001 Dieckhaus CM, Santos WL, Sofia RD, Macdonald TL. The chemistry, toxicology, and identification in rat and human urine of 4-hydroxy-5-phenyl-1,3-oxazaperhydroin-2-one: A reactive metabolite in felbamate bioactivation Chemical Research in Toxicology. 14: 958-964. PMID 11511169 DOI: 10.1021/Tx000139N  0.721
2001 Deveau AM, Labroli MA, Dieckhaus CM, Barthen MT, Smith KS, Macdonald TL. The synthesis of amino-acid functionalized beta-carbolines as topoisomerase II inhibitors. Bioorganic & Medicinal Chemistry Letters. 11: 1251-5. PMID 11392530 DOI: 10.1016/S0960-894X(01)00136-6  0.723
2001 Dieckhaus CM, Roller SG, Santos WL, Sofia RD, Macdonald TL. Role of glutathione S-transferases A1-1, M1-1, and P1-1 in the detoxification of 2-phenylpropenal, a reactive felbamate metabolite Chemical Research in Toxicology. 14: 511-516. PMID 11368548 DOI: 10.1021/Tx000141E  0.733
2000 Dieckhaus CM, Miller TA, Sofia RD, Macdonald TL. A mechanistic approach to understanding species differences in felbamate bioactivation: relevance to drug-induced idiosyncratic reactions. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 28: 814-22. PMID 10859156  0.528
2000 Thompson CD, Miller TA, Barthen MT, Dieckhaus CM, Sofia RD, Macdonald TL. The synthesis, in vitro reactivity, and evidence for formation in humans of 5-phenyl-1,3-oxazinane-2,4-dione, a metabolite of felbamate. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 28: 434-9. PMID 10725312  0.593
2000 Miller TA, Dieckhaus CM, Macdonald TL. A facile, one-pot procedure for the preparation of 2-phenyl-1,3-propanediol monocarbamate, a metabolite of felbamate Organic Process Research and Development. 4: 611-612. DOI: 10.1021/Op990198B  0.47
Show low-probability matches.